CompletedNCT00006316
Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs
Studying Histoplasmosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Mitch Goldman
- Enrollment
- 50 target
- Eligibility
- 13 years · All sexes
Study locations (13)
- Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States
- University of California San Francisco, San Francisco, California, United States
- Emory Univ, Atlanta, Georgia, United States
- Cook County Hosp, Chicago, Illinois, United States
- Indiana Univ Hosp, Indianapolis, Indiana, United States
- Methodist Hosp of Indiana / Life Care Clinic, Indianapolis, Indiana, United States
- Wishard Hosp, Indianapolis, Indiana, United States
- Univ of Nebraska Med Ctr, Omaha, Nebraska, United States
- Bellevue Hosp / New York Univ Med Ctr, New York, New York, United States
- Univ of Cincinnati, Cincinnati, Ohio, United States
- Ohio State Univ Hosp Clinic, Columbus, Ohio, United States
- Julio Arroyo, West Columbia, South Carolina, United States
- Univ of Texas, Southwestern Med Ctr of Dallas, Dallas, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00006316 on ClinicalTrials.govOther trials for Histoplasmosis
Additional recruiting or active studies for the same condition.